{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T10:40:59Z","timestamp":1756896059740,"version":"3.40.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.burns.2024.03.033","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T04:10:01Z","timestamp":1712203801000},"page":"1614-1620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Topical erythropoietin for the management of scleral necrosis after ocular chemical burns"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4457-8077","authenticated-orcid":false,"given":"Sepehr","family":"Feizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatema","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5079-7239","authenticated-orcid":false,"given":"Sadid","family":"Hooshmandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Esfandiari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.burns.2024.03.033_bib1","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jamaophthalmol.2016.2645","article-title":"Epidemiologic trends of chemical ocular burns in the United States","volume":"134","author":"Haring","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.burns.2024.03.033_bib2","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/jbcr\/iraa016","article-title":"Tenonplasty combined with amniotic membrane transplantation for patients with severe ocular burns induced anterior segment necrosis","volume":"41","author":"Peng","year":"2020","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2024.03.033_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/BCR.0b013e31822b0f29","article-title":"Management of ocular conditions in the burn unit: thermal and chemical burns and Stevens-Johnson syndrome\/toxic epidermal necrolysis","volume":"32","author":"Lin","year":"2011","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2024.03.033_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/ICO.0000000000001807","article-title":"Scleral ischemia in acute ocular chemical injury: long-term impact on rehabilitation with limbal stem cell therapy","volume":"38","author":"Gupta","year":"2019","journal-title":"Cornea"},{"key":"10.1016\/j.burns.2024.03.033_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.survophthal.2017.09.005","article-title":"Treatment of acute ocular chemical burns","volume":"63","author":"Sharma","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.burns.2024.03.033_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ICU.0b013e32833a8da2","article-title":"Management of ocular thermal and chemical injuries, including amniotic membrane therapy","volume":"21","author":"Fish","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.burns.2024.03.033_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jtos.2022.12.005","article-title":"Management of scleral melt","volume":"27","author":"Ahearn","year":"2023","journal-title":"Ocul Surf"},{"key":"10.1016\/j.burns.2024.03.033_bib8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/ICO.0000000000002570","article-title":"Topical erythropoietin as a novel treatment for necrotizing scleritis after pterygium surgery: a pilot study","volume":"40","author":"Feizi","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.burns.2024.03.033_bib9","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1080\/09273948.2021.1934485","article-title":"Topical erythropoietin for treatment of scleral necrosis","volume":"30","author":"Feizi","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.burns.2024.03.033_bib10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.survophthal.2021.06.002","article-title":"Use of erythropoietin in ophthalmology: a review","volume":"67","author":"Feizi","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.burns.2024.03.033_bib11","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/bjo.85.11.1379","article-title":"A new classification of ocular surface burns","volume":"85","author":"Dua","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.burns.2024.03.033_bib12","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.4103\/ijo.IJO_3148_21","article-title":"The role of Tenonplasty in the management of limbal and scleral ischemia due to acute ocular chemical burns","volume":"70","author":"Sharma","year":"2022","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.burns.2024.03.033_bib13","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00417-012-2030-8","article-title":"Visual rehabilitation with keratoprosthesis after tenonplasty as the primary globe-saving procedure for severe ocular chemical injuries","volume":"250","author":"Iyer","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.burns.2024.03.033_bib14","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/ICO.0000000000000576","article-title":"Tenonplasty combined with free oral buccal mucosa autografts for repair of sclerocorneal melt caused by chemical burns","volume":"34","author":"Wang","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.burns.2024.03.033_bib15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/ICO.0000000000001256","article-title":"Selective localized tenonplasty for corneal burns based on the findings of ocular surface fluorescein angiography","volume":"36","author":"Tabatabaei","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.burns.2024.03.033_bib16","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood-2003-01-0223","article-title":"Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization","volume":"102","author":"Heeschen","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.burns.2024.03.033_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2008.07014.x","article-title":"The non-haematopoietic biological effects of erythropoietin","volume":"141","author":"Arcasoy","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.burns.2024.03.033_bib18","first-page":"587","article-title":"Erythropoietin and growth factors exhibit differential angiogenic potential in mouse heart","volume":"22","author":"Pagonopoulou","year":"2008","journal-title":"Vivo"},{"key":"10.1016\/j.burns.2024.03.033_bib19","first-page":"526","article-title":"Erythropoietin deficiency decreases vascular stability in mice","volume":"118","author":"Chen","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.burns.2024.03.033_bib20","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2119\/molmed.2011.00414","article-title":"The receptor that tames the innate immune response","volume":"18","author":"Brines","year":"2012","journal-title":"Mol Med"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030541792400113X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030541792400113X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T14:34:16Z","timestamp":1718030056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030541792400113X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S030541792400113X"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2024.03.033","relation":{},"ISSN":["0305-4179"],"issn-type":[{"type":"print","value":"0305-4179"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical erythropoietin for the management of scleral necrosis after ocular chemical burns","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2024.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}